Takeda Pharmaceutical Co Ltd
TSE:4502

Watchlist Manager
Takeda Pharmaceutical Co Ltd Logo
Takeda Pharmaceutical Co Ltd
TSE:4502
Watchlist
Price: 4 213 JPY 0.29% Market Closed
Market Cap: 6.7T JPY
Have any thoughts about
Takeda Pharmaceutical Co Ltd?
Write Note

Relative Value

The Relative Value of one Takeda Pharmaceutical Co Ltd stock under the Base Case scenario is 6 574.77 JPY. Compared to the current market price of 4 213 JPY, Takeda Pharmaceutical Co Ltd is Undervalued by 36%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
6 574.77 JPY
Undervaluation 36%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
80
vs Industry
60
Median 3Y
1.6
Median 5Y
1.6
Industry
2.6
Forward
1.5
vs History
28
vs Industry
9
Median 3Y
28.1
Median 5Y
28.8
Industry
23
Forward
53.5
vs History
22
vs Industry
37
Median 3Y
6.8
Median 5Y
6.9
Industry
17.8
vs History
46
vs Industry
2
Median 3Y
10.9
Median 5Y
10.6
Industry
25.4
vs History
92
vs Industry
64
Median 3Y
0.9
Median 5Y
1
Industry
2.2
vs History
74
vs Industry
43
Median 3Y
2.5
Median 5Y
2.6
Industry
2.8
Forward
2.4
vs History
63
vs Industry
50
Median 3Y
3.7
Median 5Y
3.8
Industry
5.4
vs History
49
vs Industry
31
Median 3Y
9
Median 5Y
9.4
Industry
13.7
Forward
9.2
vs History
33
vs Industry
8
Median 3Y
21.4
Median 5Y
25.2
Industry
17.2
Forward
47.3
vs History
23
vs Industry
27
Median 3Y
10.6
Median 5Y
11.1
Industry
16.5
vs History
23
vs Industry
10
Median 3Y
11.8
Median 5Y
18.2
Industry
19.3
vs History
74
vs Industry
65
Median 3Y
0.7
Median 5Y
0.8
Industry
2

Multiples Across Competitors

Competitors Multiples
Takeda Pharmaceutical Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
JP
Takeda Pharmaceutical Co Ltd
TSE:4502
6.6T JPY 1.5 44.1 9.4 26.8
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
756.5B USD 18.5 90.4 48.6 54.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.4 27.8
US
Johnson & Johnson
NYSE:JNJ
364.1B USD 4.2 24.8 12 15.6
US
Merck & Co Inc
NYSE:MRK
248.4B USD 3.9 20.5 10.4 12.4
CH
Roche Holding AG
SIX:ROG
208.5B CHF 3.6 18.1 10.2 12.1
CH
Novartis AG
SIX:NOVN
181.2B CHF 4.2 12.6 10 14.9
UK
AstraZeneca PLC
LSE:AZN
159.6B GBP 4.1 31.5 169.4 253.8
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
JP
Takeda Pharmaceutical Co Ltd
TSE:4502
Average P/E: 34.6
44.1
107%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
90.4
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
24.8
-22%
US
Merck & Co Inc
NYSE:MRK
20.5
7 336%
CH
Roche Holding AG
SIX:ROG
18.1
32%
CH
Novartis AG
SIX:NOVN
12.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.5
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top